PIQD: the once a day protease inhibitor regimens. Ritonavir boosted atazanavir vs. ritonavir boosted fosamprenavir used in combination with tenofovir and emtricitabine in HIV-1 infected antiretroviral treatment-naive patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Atazanavir; Emtricitabine/tenofovir disoproxil fumarate; Fosamprenavir; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms PIQD
- 15 Jan 2014 Biomarkers information updated
- 27 Apr 2010 Actual end date (Mar 2010) and actual number of patients (76) added as reported by ClinicalTrials.gov.
- 27 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.